CATEGORIES

Newsweek

ENTERPRISING IDEALISTS

Collaborative Tech to Develop New, Affordable Drugs

time-read
9 mins  |
December 24, 2021
How the Queen of Christmas Got Her Crown
Bloomberg Businessweek

How the Queen of Christmas Got Her Crown

It seems to be an accepted fact that Mariah Carey is the Queen of Christmas.

time-read
2 mins  |
December 20, 2021
How a revered vegetarian restaurant barely avoided disaster to do better than ever, despite everything
Bloomberg Businessweek

How a revered vegetarian restaurant barely avoided disaster to do better than ever, despite everything

Dirt Candy’s pandemic survival story

time-read
10+ mins  |
December 20, 2021
What You Get When You Cross a Frog - With an Algorithm
Bloomberg Businessweek

What You Get When You Cross a Frog - With an Algorithm

The creation of “living machines” is a new, odd frontier in robotics

time-read
5 mins  |
December 20, 2021
Tesla Takes Its Critics to Court
Bloomberg Businessweek

Tesla Takes Its Critics to Court

Chinese customers and bloggers who complain about its cars are increasingly the targets of lawsuits

time-read
5 mins  |
December 20, 2021
Luxury Companies' Pandemic Lessons
Bloomberg Businessweek

Luxury Companies' Pandemic Lessons

Covid lockdowns and the growth of e-commerce are changing merchants’ playbooks

time-read
4 mins  |
December 20, 2021
FEAR GREED - Fascination
Bloomberg Businessweek

FEAR GREED - Fascination

A wild, emotional year drew investors to meme stocks and Bored Ape NFTs—and changed markets

time-read
10+ mins  |
December 20, 2021
Power to the People, Not the Platform
Bloomberg Businessweek

Power to the People, Not the Platform

India’s gig workers are using social media to demand better treatment. Is the ballot box next?

time-read
4 mins  |
December 20, 2021
I'll Have What He's Making
Bloomberg Businessweek

I'll Have What He's Making

Employees can make more when they know what their peers pull in

time-read
4 mins  |
December 20, 2021
The Travel Recovery That Wasn't
Bloomberg Businessweek

The Travel Recovery That Wasn't

Most of us did leave the house this year—we just didn’t go very far.

time-read
3 mins  |
December 20, 2021
A Labor Enforcer Readies Her Arsenal
Bloomberg Businessweek

A Labor Enforcer Readies Her Arsenal

The NLRB’s Jennifer Abruzzo wants more injunctions against employers who violate the law

time-read
5 mins  |
December 20, 2021
What a Difference A Year Makes
Bloomberg Businessweek

What a Difference A Year Makes

Halo Infinite was far off track last summer. Now a risky delay seems to have paid off

time-read
7 mins  |
December 13, 2021
Bloomberg Businessweek

The Swiss Army Vaccine

There are promising signs that a single vaccine could protect against multiple coronaviruses and variants. But with pharma companies invested in boosters, will anyone pay to develop it?

time-read
10+ mins  |
December 13, 2021
Bloomberg Businessweek

The ESG Mirage

Sustainable investing is mostly about sustaining profits. MSCI, the largest ESG rating company, doesn’t even try to measure the impact of a corporation on the Earth and its people

time-read
10+ mins  |
December 13, 2021
The SEC Puts the Brakes On EV SPAC-Mania
Bloomberg Businessweek

The SEC Puts the Brakes On EV SPAC-Mania

Young electric car companies have drawn big valuations from investors. Now they’re drawing regulator scrutiny, too

time-read
4 mins  |
December 13, 2021
The No-Stress Saloon
Bloomberg Businessweek

The No-Stress Saloon

Mercedes’s first electric car, the yachtlike EQS, will lull away your range anxiety.

time-read
3 mins  |
December 13, 2021
INTERVIEW DATING
Bloomberg Businessweek

INTERVIEW DATING

Looking for work has become much like looking for love

time-read
3 mins  |
December 13, 2021
Covid Pills Face a Truth Problem
Bloomberg Businessweek

Covid Pills Face a Truth Problem

Merck’s new medicine is set to enter a landscape where misinformation is widespread

time-read
6 mins  |
December 13, 2021
Bloomberg Businessweek

The U.S. Is Falling Behind on Women's Rights

With the Supreme Court poised to restrict access to abortion, the nation takes another step backward

time-read
5 mins  |
December 13, 2021
Bloomberg Businessweek

A Global Urge to Lie Flat

Burned-out millennials and Gen Zers are quitting their jobs by the millions

time-read
10+ mins  |
December 13, 2021
Addicted to Work
Bloomberg Businessweek

Addicted to Work

In Out of Office, two remote-work evangelists uncover the cause of all your stress: Your job

time-read
3 mins  |
December 13, 2021
IS YOUR HIRING IN NEED OF HELP?
Inc.

IS YOUR HIRING IN NEED OF HELP?

TIP SHEET

time-read
2 mins  |
Winter 2021/2022
Chris and Shivani VS. the World
Inc.

Chris and Shivani VS. the World

Venture investor Chris Sacca talks with Shivani Siroya, founder of fintech company Tala, about scaling up your business without locking it down.

time-read
6 mins  |
Winter 2021/2022
Meet Your Future Banker
Inc.

Meet Your Future Banker

In 2021, Brian Armstrong proved the digital economy doesn’t need the U.S. Dollar. Here’s why that’s important—why it matters to you —and why it makes his juggernaut, coinbase, inc.’s company of the year.

time-read
10+ mins  |
Winter 2021/2022
Fake It Till You Make... A Mess
Inc.

Fake It Till You Make... A Mess

When the media company Ozy unraveled last fall, its CEO, Carlos Watson-the would-be wizard of Ozy-stood accused of inflating performance, inventing partners, and looking the other way when his co-founder impersonated a YouTube exec to potential investors. It wasn't, however, the first time a finding hungry, win-at-any-cost entrepreneur would take preposterously desperate measures: Cook the books? Check. Conspire to traffic cocaine? Hey, it's financing! Dress like Steve Jobs? Sadly, yes. Take a look at some who crossed the line from unbridled hype to “Let me explain, Your Honor.” – BILL SHAPIRO

time-read
4 mins  |
Winter 2021/2022
The Future of...Fixing Pharmaceuticals
Inc.

The Future of...Fixing Pharmaceuticals

Eric Edwards is cofounder and chief executive officer of Phlow, a public benefit pharmaceutical corporation. He previously co-founded pharmaceutical company Kaléo, where, among other roles, he was responsible for overall scientific strategy and pharmaceutical development programs. Following an unprecedented year for the pharmaceutical industry, including leaps in vaccine technology and supply chain shortages, Inc. asked Edwards to share his vision for the future of pharmaceuticals.

time-read
1 min  |
Winter 2021/2022
The New Fighter At the CFPB
Bloomberg Businessweek

The New Fighter At the CFPB

Rohit Chopra wants to know more about tech companies’ plans for financial products

time-read
5 mins  |
December 06, 2021
Next on Your Plate: Bug Burgers
Bloomberg Businessweek

Next on Your Plate: Bug Burgers

The faux-meat industry is starting to explore fruit fly patties and mealworm nuggets

time-read
4 mins  |
December 06, 2021
Ready Aim Omicron!
Bloomberg Businessweek

Ready Aim Omicron!

Drugmakers always knew variants would arise. The latest will test their preparedness

time-read
5 mins  |
December 06, 2021
Treasure Hunters Of the Stalled Supply Chain
Bloomberg Businessweek

Treasure Hunters Of the Stalled Supply Chain

For salvage companies, an unclaimed shipping container is a potentially profitable mystery box

time-read
6 mins  |
December 06, 2021